Nordic Life Science Platform - Fast-track China Entry

The Nordic Life Science Platform (www.NLSP.dk) gives foreign Life Science companies a more safe, efficient, and easier access to the rapidly expanding Chinese healthcare market by taking advantage of the preferential policies and opportunities at Hainan Boao Lecheng International Medical Tourism Pilot Zone (HBL) and the Guangdong-Hong Kong-Macao Great Bay Area (GBA). We match the demand for innovative medtech, healthtech, drugs, and rehabilitation equipment by the currently 32 hospitals at HBL and 45 designated hospitals in GBA with the supply of foreign life science companies and that way help them access and develop new sales/export opportunities in China. NLSP is a one-stop service platform that delivers a Step-by-Step Market Entry Model that supports companies all the way from exploring, entering, and/or expanding in the Chinese healthcare market with the option to stop after each step of the process to determine the next step in China. Our experienced Team offers expert advice and supporting services such as: Project Management, Legal Advice & Assistance, IPR Protection, Medical Expert Review, Hospital Matchmaking, Contract Negotiations, Fast-track Product Approvals, CRO appointment & RWD study pre-communication, RWD study implementation & new medical product application, NMPA Product Registrations, Market Research, Contact to Potential Distributors, Contact to Potential Investors, and Company Set-up. NLSP also cooperates closely with Chinese national distributors of medical products that can open doors to the rest of the mainland China market. To learn more about the Nordic Life Science Platform, please visit www.nlsp.dk